Skip to main content
. 2015 May 27;6(26):22776–22798. doi: 10.18632/oncotarget.4309

Figure 7. Real time cell analysis of B16-F10 after treatment with drugs administered alone (C1, C2 and C3) and with drugs delivered chemically or physically via nanotubes (A0-o-C1, A0-o-C2 and A0-o-C3).

Figure 7